Marshall Wace LLP raised its position in shares of National Health Investors, Inc. (NYSE:NHI - Free Report) by 161.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 551,585 shares of the real estate investment trust's stock after buying an additional 340,712 shares during the quarter. Marshall Wace LLP owned about 1.21% of National Health Investors worth $38,225,000 at the end of the most recent quarter.
Other hedge funds have also recently modified their holdings of the company. Loomis Sayles & Co. L P boosted its holdings in National Health Investors by 42.0% in the fourth quarter. Loomis Sayles & Co. L P now owns 639 shares of the real estate investment trust's stock worth $44,000 after acquiring an additional 189 shares in the last quarter. Jones Financial Companies Lllp grew its position in National Health Investors by 781.2% during the 4th quarter. Jones Financial Companies Lllp now owns 890 shares of the real estate investment trust's stock valued at $62,000 after purchasing an additional 789 shares during the last quarter. Venturi Wealth Management LLC bought a new stake in National Health Investors during the 4th quarter valued at about $63,000. NewEdge Advisors LLC purchased a new position in National Health Investors in the fourth quarter worth about $83,000. Finally, KBC Group NV lifted its stake in shares of National Health Investors by 61.4% in the fourth quarter. KBC Group NV now owns 2,019 shares of the real estate investment trust's stock worth $140,000 after buying an additional 768 shares in the last quarter. Institutional investors own 62.51% of the company's stock.
National Health Investors Stock Up 0.2 %
Shares of NHI traded up $0.17 during midday trading on Thursday, reaching $75.71. 29,904 shares of the stock were exchanged, compared to its average volume of 220,079. The company has a market capitalization of $3.53 billion, a P/E ratio of 26.00, a PEG ratio of 4.42 and a beta of 0.79. The company has a current ratio of 10.29, a quick ratio of 10.29 and a debt-to-equity ratio of 0.92. National Health Investors, Inc. has a 52 week low of $61.65 and a 52 week high of $86.13. The company's 50 day moving average is $72.87 and its two-hundred day moving average is $72.97.
National Health Investors (NYSE:NHI - Get Free Report) last announced its quarterly earnings results on Tuesday, February 25th. The real estate investment trust reported $1.13 earnings per share for the quarter, topping the consensus estimate of $1.10 by $0.03. National Health Investors had a net margin of 38.53% and a return on equity of 10.11%. The firm had revenue of $85.75 million during the quarter, compared to analysts' expectations of $81.13 million. On average, sell-side analysts anticipate that National Health Investors, Inc. will post 4.41 earnings per share for the current year.
National Health Investors Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 2nd. Investors of record on Monday, March 31st will be paid a dividend of $0.90 per share. The ex-dividend date of this dividend is Monday, March 31st. This represents a $3.60 annualized dividend and a dividend yield of 4.76%. National Health Investors's dividend payout ratio (DPR) is presently 115.38%.
Wall Street Analysts Forecast Growth
A number of research analysts have recently issued reports on the company. Truist Financial upped their price target on National Health Investors from $70.00 to $76.00 and gave the company a "hold" rating in a report on Wednesday, March 19th. Wedbush reaffirmed an "outperform" rating and set a $88.00 price target on shares of National Health Investors in a report on Monday, March 17th. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the company's stock. According to MarketBeat, National Health Investors has a consensus rating of "Hold" and a consensus price target of $85.50.
View Our Latest Stock Analysis on NHI
National Health Investors Profile
(
Free Report)
Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Further Reading

Before you consider National Health Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.
While National Health Investors currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.